Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Permanent pacemaker dependency in patients with new left bundle branch block and new first degree atrioventricular block after transcatheter aortic valve implantation.
Hartrampf B, Jochheim D, Steffen J, Czermak T, Sadoni S, Lemmermöhle E, Klier I, Estner HL, Massberg S, Mehilli J, Lackermair K, Fichtner S. Hartrampf B, et al. Among authors: mehilli j. Sci Rep. 2021 Dec 21;11(1):24383. doi: 10.1038/s41598-021-03667-0. Sci Rep. 2021. PMID: 34934073 Free PMC article. Clinical Trial.
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schömig A, Kastrati A; ISAR-DESIRE 2 Investigators. Mehilli J, et al. J Am Coll Cardiol. 2010 Jun 15;55(24):2710-6. doi: 10.1016/j.jacc.2010.02.009. Epub 2010 Mar 11. J Am Coll Cardiol. 2010. PMID: 20226618 Free article. Clinical Trial.
Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
Kufner S, Massberg S, Dommasch M, Byrne RA, Tiroch K, Ranftl S, Fusaro M, Schömig A, Kastrati A, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents Trial Investigators. Kufner S, et al. Among authors: mehilli j. Catheter Cardiovasc Interv. 2011 Aug 1;78(2):161-6. doi: 10.1002/ccd.22823. Epub 2011 Mar 11. Catheter Cardiovasc Interv. 2011. PMID: 21400652 Clinical Trial.
Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
Sibbing D, Bernlochner I, Schulz S, Massberg S, Schömig A, Mehilli J, Kastrati A. Sibbing D, et al. Among authors: mehilli j. J Am Coll Cardiol. 2012 Jul 31;60(5):369-77. doi: 10.1016/j.jacc.2012.02.044. Epub 2012 Jun 6. J Am Coll Cardiol. 2012. PMID: 22682553 Free article. Clinical Trial.
Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
Kufner S, Byrne RA, Mehilli J, Massberg S, Birkmeier KA, Schulz S, Pache J, Schömig A, Kastrati A. Kufner S, et al. Among authors: mehilli j. Catheter Cardiovasc Interv. 2013 Nov 15;82(6):E769-76. doi: 10.1002/ccd.24741. Epub 2013 Jun 11. Catheter Cardiovasc Interv. 2013. PMID: 23754254 Clinical Trial.
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J, Richardt G, Valgimigli M, Schulz S, Singh A, Abdel-Wahab M, Tiroch K, Pache J, Hausleiter J, Byrne RA, Ott I, Ibrahim T, Fusaro M, Seyfarth M, Laugwitz KL, Massberg S, Kastrati A; ISAR-LEFT-MAIN 2 Study Investigators. Mehilli J, et al. J Am Coll Cardiol. 2013 Dec 3;62(22):2075-82. doi: 10.1016/j.jacc.2013.07.044. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973699 Free article. Clinical Trial.
434 results